ERBB2 and gastroesophageal junction adenocarcinoma: HER2-negative gastric or gastroesophageal junction adenocarcinoma, biliary tract cancer, cervical cancer, high-risk early-stage TNBC, esophageal carcinoma, head and neck squamous cell carcinoma